Chee Conley 4
4 · Syros Pharmaceuticals, Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Chee Conley
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2023-12-02+86,000→ 86,000 total→ Common Stock (86,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F2]These RSUs will vest as to one third (1/3rd) of the shares underlying the award on December 31, 2024 and as to an additional one third (1/3rd) of such shares at the end of each successive year thereafter.